1. OP0126 A phase 2 study of safety and efficacy of anabasum (JBT-101) in systemic sclerosis. (15th June 2017) Authors: Spiera, R; Hummers, L; Chung, L; Frech, T; Domsic, R; Furst, D; Gordon, J; Mayes, M; Simms, R; Constantine, S; White, B Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 105 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗